Alghamdi Saeed Mardy, Alzahrani Abdulaziz A, Dairi Mohammad S, Alwafi Hassan, Aldhahir Abdulelah M, Alqahtani Jaber S, Alqahtani Mohammed M, Alanazi Abdullah M, Alqarni Abdullah A, Siraj Rayan A, Alghamdi Noha Saeed, Alzahrani Hassan A, Alhindi Abdulghani A
Clinical Technology Department, Respiratory Care Program, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21961, Saudi Arabia.
Clinical Technology Department, Respiratory Care Program, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241307066. doi: 10.1177/17534666241307066.
Productive cough with sputum is a prominent sign generally associated with respiratory diseases, including chronic obstructive pulmonary disease (COPD). Airway clearance devices are an option for COPD management, but physicians' preferences for and clinical practice with them are not known.
This study aims to explore preferences for and clinical practice with airway clearance devices among physicians in Saudi Arabia.
An observational, cross-sectional survey.
A self-administered questionnaire was conducted between October 2022 and September 2023, which included a review of respiratory medication prescriptions by physicians for patients with COPD. The analysis was performed using the Statistical Package for the Social Sciences.
The participants were 445 physicians. The majority were female, accounting for 64.3% of the sample. Flutter and Acapella were the most commonly preferred airway clearance devices (45.8% and 20.7%, respectively). Among the participants, 12.6% reported unfamiliarity with any of the mentioned devices. Of the participants, 43.6% "usually" suggested the devices for patients with daily, difficult-to-clear, thick sputum, while 27% "sometimes" recommended them to COPD patients who had experienced four exacerbations or more. In routine clinical practice, physicians prescribe pharmacological therapies as the main treatment. The prescribing data showed that in the last year, there was no record of prescribed airway clearance devices for COPD by physicians.
Family and pulmonary physicians prefer Flutter and Acapella devices, but a significant number of physicians are unaware of such devices. Prescribing data showed no record of prescribed airway clearance devices for COPD management. Further initiatives are needed to increase awareness in clinical practice.
伴有痰液的有效咳嗽是一个突出症状，通常与包括慢性阻塞性肺疾病（COPD）在内的呼吸道疾病相关。气道廓清装置是慢性阻塞性肺疾病管理的一种选择，但医生对其的偏好和临床应用情况尚不清楚。
本研究旨在探讨沙特阿拉伯医生对气道廓清装置的偏好和临床应用情况。
一项观察性横断面调查。
在2022年10月至2023年9月期间进行了一项自填式问卷调查，其中包括医生对慢性阻塞性肺疾病患者呼吸药物处方的审查。使用社会科学统计软件包进行分析。
参与者为445名医生。大多数为女性，占样本的64.3%。弗洛特（Flutter）和阿凯拉（Acapella）是最常被偏好的气道廓清装置（分别为45.8%和20.7%）。在参与者中，12.6%报告对任何提及的装置不熟悉。在参与者中，43.6%“通常”会为每天有难以咳出的浓稠痰液的患者推荐这些装置，而27%“有时”会将其推荐给经历过四次或更多次病情加重的慢性阻塞性肺疾病患者。在常规临床实践中，医生将药物治疗作为主要治疗方法。处方数据显示，在过去一年中，医生没有为慢性阻塞性肺疾病患者开具气道廓清装置的记录。
家庭医生和肺科医生更喜欢弗洛特和阿凯拉装置，但相当多的医生并不了解这些装置。处方数据显示没有为慢性阻塞性肺疾病管理开具气道廓清装置的记录。需要进一步采取措施提高临床实践中的认知度。
